132 related articles for article (PubMed ID: 38428411)
1. Unleashing a safe and potent pro-senescence anti-tumor strategy.
Chen S; Sun B; Dong Z
Cancer Cell; 2024 Apr; 42(4):504-507. PubMed ID: 38428411
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells.
Colucci M; Zumerle S; Bressan S; Gianfanti F; Troiani M; Valdata A; D'Ambrosio M; Pasquini E; Varesi A; Cogo F; Mosole S; Dongilli C; Desbats MA; Contu L; Revankdar A; Chen J; Kalathur M; Perciato ML; Basilotta R; Endre L; Schauer S; Othman A; Guccini I; Saponaro M; Maraccani L; Bancaro N; Lai P; Liu L; Pernigoni N; Mele F; Merler S; Trotman LC; Guarda G; Calì B; Montopoli M; Alimonti A
Cancer Cell; 2024 Apr; 42(4):646-661.e9. PubMed ID: 38428412
[TBL] [Abstract][Full Text] [Related]
3. Cross-Linked Polyphenol-Based Drug Nano-Self-Assemblies Engineered to Blockade Prostate Cancer Senescence.
Nagesh PKB; Chowdhury P; Hatami E; Kumari S; Kashyap VK; Tripathi MK; Wagh S; Meibohm B; Chauhan SC; Jaggi M; Yallapu MM
ACS Appl Mater Interfaces; 2019 Oct; 11(42):38537-38554. PubMed ID: 31553876
[TBL] [Abstract][Full Text] [Related]
4. Blockade of γ-Glutamylcyclotransferase Enhances Docetaxel Growth Inhibition of Prostate Cancer Cells.
Takagi H; Ii H; Kageyama S; Hanada E; Taniguchi K; Yoshiya T; Chano T; Kawauchi A; Nakata S
Anticancer Res; 2019 Sep; 39(9):4811-4816. PubMed ID: 31519583
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapeutic HCW9218 augments anti-tumor activity of chemotherapy via NK cell-mediated reduction of therapy-induced senescent cells.
Chaturvedi P; George V; Shrestha N; Wang M; Dee MJ; Zhu X; Liu B; Egan J; D'Eramo F; Spanoudis C; Gallo V; Echeverri C; You L; Kong L; Fang B; Jeng EK; Rhode PR; Wong HC
Mol Ther; 2022 Mar; 30(3):1171-1187. PubMed ID: 35051615
[TBL] [Abstract][Full Text] [Related]
6. Distinct phenotypes and 'bystander' effects of senescent tumour cells induced by docetaxel or immunomodulatory cytokines.
Sapega O; Mikyšková R; Bieblová J; Mrázková B; Hodný Z; Reiniš M
Int J Oncol; 2018 Nov; 53(5):1997-2009. PubMed ID: 30226595
[TBL] [Abstract][Full Text] [Related]
7. Synergistic anti-tumor effects of Liraglutide, a glucagon-like peptide-1 receptor agonist, along with Docetaxel on LNCaP prostate cancer cell line.
Eftekhari S; Montazeri H; Tarighi P
Eur J Pharmacol; 2020 Jul; 878():173102. PubMed ID: 32283060
[TBL] [Abstract][Full Text] [Related]
8. Natural Polyphenols Targeting Senescence: A Novel Prevention and Therapy Strategy for Cancer.
Bian Y; Wei J; Zhao C; Li G
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31968672
[TBL] [Abstract][Full Text] [Related]
9. Different sensitivities of senescent breast cancer cells to immune cell-mediated cytotoxicity.
Inao T; Kotani H; Iida Y; Kartika ID; Okimoto T; Tanino R; Shiba E; Harada M
Cancer Sci; 2019 Sep; 110(9):2690-2699. PubMed ID: 31250942
[TBL] [Abstract][Full Text] [Related]
10. Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity.
Chien Y; Scuoppo C; Wang X; Fang X; Balgley B; Bolden JE; Premsrirut P; Luo W; Chicas A; Lee CS; Kogan SC; Lowe SW
Genes Dev; 2011 Oct; 25(20):2125-36. PubMed ID: 21979375
[TBL] [Abstract][Full Text] [Related]
11. Senescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1.
Laine A; Sihto H; Come C; Rosenfeldt MT; Zwolinska A; Niemelä M; Khanna A; Chan EK; Kähäri VM; Kellokumpu-Lehtinen PL; Sansom OJ; Evan GI; Junttila MR; Ryan KM; Marine JC; Joensuu H; Westermarck J
Cancer Discov; 2013 Feb; 3(2):182-97. PubMed ID: 23306062
[TBL] [Abstract][Full Text] [Related]
12. Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging.
Muñoz DP; Yannone SM; Daemen A; Sun Y; Vakar-Lopez F; Kawahara M; Freund AM; Rodier F; Wu JD; Desprez PY; Raulet DH; Nelson PS; van 't Veer LJ; Campisi J; Coppé JP
JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184599
[TBL] [Abstract][Full Text] [Related]
13. Pentoxifylline sensitizes human cervical tumor cells to cisplatin-induced apoptosis by suppressing NF-kappa B and decreased cell senescence.
Hernandez-Flores G; Ortiz-Lazareno PC; Lerma-Diaz JM; Dominguez-Rodriguez JR; Jave-Suarez LF; Aguilar-Lemarroy Adel C; de Celis-Carrillo R; del Toro-Arreola S; Castellanos-Esparza YC; Bravo-Cuellar A
BMC Cancer; 2011 Nov; 11():483. PubMed ID: 22074157
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of adapalene.
Michel S; Jomard A; Démarchez M
Br J Dermatol; 1998 Oct; 139 Suppl 52():3-7. PubMed ID: 9990413
[TBL] [Abstract][Full Text] [Related]
15. Co-Delivery of Docetaxel and Curcumin via Nanomicelles for Enhancing Anti-Ovarian Cancer Treatment.
Hu Y; Ran M; Wang B; Lin Y; Cheng Y; Zheng S
Int J Nanomedicine; 2020; 15():9703-9715. PubMed ID: 33299312
[TBL] [Abstract][Full Text] [Related]
16. Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis.
Guccini I; Revandkar A; D'Ambrosio M; Colucci M; Pasquini E; Mosole S; Troiani M; Brina D; Sheibani-Tezerji R; Elia AR; Rinaldi A; Pernigoni N; Rüschoff JH; Dettwiler S; De Marzo AM; Antonarakis ES; Borrelli C; Moor AE; Garcia-Escudero R; Alajati A; Attanasio G; Losa M; Moch H; Wild P; Egger G; Alimonti A
Cancer Cell; 2021 Jan; 39(1):68-82.e9. PubMed ID: 33186519
[TBL] [Abstract][Full Text] [Related]
17. Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression.
Harris AR; Perez MJ; Munson JM
BMC Cancer; 2018 Jul; 18(1):718. PubMed ID: 29976154
[TBL] [Abstract][Full Text] [Related]
18. The identification of senescence-specific genes during the induction of senescence in prostate cancer cells.
Schwarze SR; Fu VX; Desotelle JA; Kenowski ML; Jarrard DF
Neoplasia; 2005 Sep; 7(9):816-23. PubMed ID: 16229804
[TBL] [Abstract][Full Text] [Related]
19. Wogonin induces cellular senescence in breast cancer via suppressing TXNRD2 expression.
Yang D; Guo Q; Liang Y; Zhao Y; Tian X; Ye Y; Tian J; Wu T; Lu N
Arch Toxicol; 2020 Oct; 94(10):3433-3447. PubMed ID: 32671444
[TBL] [Abstract][Full Text] [Related]
20. Tumor growth accelerated by chemotherapy-induced senescent cells is suppressed by treatment with IL-12 producing cellular vaccines.
Simova J; Sapega O; Imrichova T; Stepanek I; Kyjacova L; Mikyskova R; Indrova M; Bieblova J; Bubenik J; Bartek J; Hodny Z; Reinis M
Oncotarget; 2016 Aug; 7(34):54952-54964. PubMed ID: 27448982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
